D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
WVE holding history
Wave Life Sciences, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
WVE overviewAll 13F holders of WVEFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,772,228
- Value
- $10.3M
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,772,228 | $10.3M | <0.1% | +1,699,923+2,351.0% | Added | Holders |
| Q1 2026 | 72,305 | $524.2K | <0.1% | −193,827−72.8% | Reduced | Holders |
| Q4 2025 | 266,132 | $4.52M | <0.1% | +266,132 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −271,474−100.0% | Sold out | Holders |
| Q2 2025 | 271,474 | $1.76M | <0.1% | +164,920+154.8% | Added | Holders |
| Q1 2025 | 106,554 | $861.0K | <0.1% | −609,699−85.1% | Reduced | Holders |
| Q4 2024 | 716,253 | $8.86M | <0.1% | +297,792+71.2% | Added | Holders |
| Q3 2024 | 418,461 | $3.43M | <0.1% | +309,894+285.4% | Added | Holders |
| Q2 2024 | 108,567 | $541.7K | <0.1% | −176,525−61.9% | Reduced | Holders |
| Q1 2024 | 285,092 | $1.76M | <0.1% | +285,092 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −307,175−100.0% | Sold out | Holders |
| Q3 2022 | 307,175 | $1.11M | <0.1% | −633,290−67.3% | Reduced | Holders |
| Q2 2022 | 940,465 | $3.06M | <0.1% | −150,835−13.8% | Reduced | Holders |
| Q1 2022 | 1,091,300 | $2.18M | <0.1% | −18,989−1.7% | Reduced | Holders |
| Q4 2021 | 1,110,289 | $3.49M | <0.1% | +8,639+0.8% | Added | Holders |
| Q3 2021 | 1,101,650 | $5.40M | <0.1% | −153,910−12.3% | Reduced | Holders |
| Q2 2021 | 1,255,560 | $8.36M | <0.1% | −6,549−0.5% | Reduced | Holders |
| Q1 2021 | 1,262,109 | $7.08M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.